TRIAL UPDATE: First patient was enrolled in the EORTC 1945

July 1, 2021

OligoRARE trial in oligometastatic rare cancers OligoRARE is an international study with 6 participating countries in Europe and a collaboration with the British Columbia Cancer Agency in Canada.

EORTC would like to thank The Anticancer Fund and Rising Tide Group for supporting this trial.